Bio-Optronics Releases New Version of CTMS Technology
Bio-Optronics' Clinical Conductor CTMS team announced new features in the latest release of Clinical Conductor
Bio-Optronics' Clinical Conductor CTMS team announced new features in the latest release of Clinical Conductor, one of which is multiple CTMS configuration flexibility. These configurations are designed for research sites, site networks, CROs, hospitals, health systems and sponsors feature sets and functionalities required by their specific organization.
In addition to the configurations in this release, Clinical Conductor includes more financial functionality to give organizations even greater insight into their study finances.
Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
